In addition to standard assay kits, Accellix develops custom assay kits tailored for specific cell therapy manufacturing workflows, including drug-release assays.
Coupled with automated and customizable analysis algorithms that dynamically classify cell subsets for each run, critical quality attributes of cell products can be easily measured for real-time monitoring and decision making.
The Accellix platform has been embraced by leading immunotherapy companies as it enables streamlining of cell phenotyping and enumeration during analytical and process development as well as manufacturing and QC of cell therapy drug products.
Typical timeline is 4-6 months depending on assay complexity and customer feedback.
The Accellix Platform automates your entire GMP cell phenotyping process from sample preparation to data acquisition and analysis, to generate rapid results directly in the manufacturing suite.
Standard Assays